glp 1 agonist and depression GLP-1s: Are We Ignoring the Psychiatric Risks? 🚨NEW BLOG ALERT🚨 From regulating

Obesity as a multisystem disease: trends in obesity rates and obesity-related complications

Research, including recent findings from the SELECT trial, indicates that GLP-1 agonists like semaglutide can significantly reduce the risk of major cardiovascular events, such as heart attacks and strokes, especially in individuals with obesity but without diabetes

Patorno, and L

Competing Interests Blair Suter, Allison Bigeh, Timothy Frommeyer, and Laxmi Mehta declare that they have no conflicts of interest

I'm on my third month and have already lost 15 pounds. Complete your intake today

Do SGLT2 inhibitors and GLP-1 receptor agonists modulate differently the risk of stroke